CLINICAL_TRIALS
trial_result
· 2012-10-26
Clinical Trial Update: Aripiprazole Augmentation of SSRI Therapy in Treatment Refractory Depression [Phase 4]
Summary
Phase 4 clinical trial evaluating aripiprazole augmentation of SSRI therapy in treatment-refractory major depressive disorder, with results posted in 2012.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Texas Southwestern Medical Center | Conditions: Major Depressive Disorder | Phase 4 | Status: COMPLETED | Results posted: 2012-10-26